1 most recent filing and news item mentioning INO. Updated every 60 seconds.
OfferingJul 31, 2026Neutral
Inovio Pharmaceuticals priced an offering of 21.1 million shares of common stock and warrants for 42.1 million shares. The move is a capital raise intended to fund ongoing operations and development pipelines.
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.